Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma

Summary

The purpose of the study is to determine whether additional doses of ipilimumab have a positive effect on survival in the treatment of advanced melanoma that has progressed after successful initial treatment with ipilimumab.

Timeline

Start

2013-03

Primary completion

2014-07

Completion

2014-07

Outcome

Outcome not reported

Stopped (Enrollment): “Discontinued early due to enrollment challenges and changes in treatment standards”

Drugs

Indications